Português
Contacts
Home
Advanced Search
Directory
Funding
Help
Subscribe RSS
Document details
Alirocumab reduces total nonfatal cardiovascular and fatal events the ODYSSEY OUTCOMES trial
Author(s):
Nicolau, José Carlos
Date:
2019
Origin:
Oasisbr
Subject(s):
RESULTADO DE TRATAMENTO
Document Type
Journal article
Language
English
Related documents
Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind, placebo-controlled tria...
Nicolau, José Carlos
more
Date:
2019
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous ...
Nicolau, José Carlos
more
Date:
2019
Back to Homepage
Top
About RCAAP
Help
© All rights reserved.
Google Analytics